Appili Therapeutics, Inc. (APLIF)
0.0068
0.00 (0.00%)
USD |
OTCM |
Oct 26, 16:00
Appili Therapeutics Cash from Operations (Quarterly) : -0.0267M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0267M |
| March 31, 2026 | -0.2064M |
| December 31, 2025 | -0.2028M |
| September 30, 2025 | -0.5859M |
| June 30, 2025 | -0.014M |
| March 31, 2025 | 0.7133M |
| December 31, 2024 | -0.33M |
| September 30, 2024 | 0.2879M |
| June 30, 2024 | -0.1103M |
| March 31, 2024 | -0.3513M |
| December 31, 2023 | 0.1729M |
| September 30, 2023 | -0.1906M |
| June 30, 2023 | -1.521M |
| March 31, 2023 | -0.8348M |
| December 31, 2022 | -0.7203M |
| September 30, 2022 | -2.385M |
| June 30, 2022 | -3.884M |
| Date | Value |
|---|---|
| March 31, 2022 | -3.068M |
| December 31, 2021 | -4.680M |
| September 30, 2021 | -2.065M |
| June 30, 2021 | -5.528M |
| March 31, 2021 | -3.444M |
| December 31, 2020 | -2.295M |
| September 30, 2020 | -2.042M |
| June 30, 2020 | -1.081M |
| March 31, 2020 | -0.8496M |
| December 31, 2019 | -0.4648M |
| September 30, 2019 | -0.7837M |
| June 30, 2019 | -1.152M |
| March 31, 2019 | -0.4755M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | -1.002M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -2.909M |
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.53M |
| Clearmind Medicine, Inc. | -1.859M |
| Lexaria Bioscience Corp. | -1.635M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.1232M |
| Free Cash Flow | -1.022M |
| Free Cash Flow Per Share (Quarterly) | -0.0002 |
| Free Cash Flow to Equity (Quarterly) | -0.15M |
| Free Cash Flow to Firm (Quarterly) | 0.1561M |
| Free Cash Flow Yield | -116.9% |